Artificial Intelligence has suddenly gone from the fringes of science to being everywhere. So how did we get here? And where's this all heading? In this new series of Science Friction, we're finding out.
…
continue reading
Contenuto fornito da Science Changing Life and Scripps Research. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Science Changing Life and Scripps Research o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
Episode 40 – Sumit Chanda: How can we prepare for the next pandemic?
Manage episode 356004294 series 1908208
Contenuto fornito da Science Changing Life and Scripps Research. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Science Changing Life and Scripps Research o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Professor Sumit Chanda is an infectious disease expert and immunologist, where he works both in the Department of Immunology and Microbiology and at Calibr, Scripps Research’s nonprofit drug discovery and development division. He has devoted his career to understanding how the immune system responds to numerous viruses, such as influenza, Dengue virus and SARS-CoV-2. Listen as we discuss everything from pandemic preparedness to drug discovery, as well as his unrelenting drive to uncover new treatment options—including for COVID-19. Episode transcript https://www.scripps.edu/_files/images/2023_images/sumit-chanda-transcript.pdf Infectious disease sleuth Sumit Chanda, PhD, joins Scripps Research and its Calibr drug discovery division https://www.scripps.edu/news-and-events/press-room/2021/20210915-chanda-calibr.html Center for Antiviral Medicines & Pandemic Preparedness https://www.campp.org/ Chanda lab website https://linktr.ee/thechandalab Twitter/Instagram @thechandalab
…
continue reading
50 episodi
Manage episode 356004294 series 1908208
Contenuto fornito da Science Changing Life and Scripps Research. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Science Changing Life and Scripps Research o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Professor Sumit Chanda is an infectious disease expert and immunologist, where he works both in the Department of Immunology and Microbiology and at Calibr, Scripps Research’s nonprofit drug discovery and development division. He has devoted his career to understanding how the immune system responds to numerous viruses, such as influenza, Dengue virus and SARS-CoV-2. Listen as we discuss everything from pandemic preparedness to drug discovery, as well as his unrelenting drive to uncover new treatment options—including for COVID-19. Episode transcript https://www.scripps.edu/_files/images/2023_images/sumit-chanda-transcript.pdf Infectious disease sleuth Sumit Chanda, PhD, joins Scripps Research and its Calibr drug discovery division https://www.scripps.edu/news-and-events/press-room/2021/20210915-chanda-calibr.html Center for Antiviral Medicines & Pandemic Preparedness https://www.campp.org/ Chanda lab website https://linktr.ee/thechandalab Twitter/Instagram @thechandalab
…
continue reading
50 episodi
Tutti gli episodi
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.